Orbimed Advisors - ADICET BIO INC ownership

ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ADICET BIO INC
ValueSharesWeighting
Q3 2023$11,401,332
-43.6%
8,322,1400.0%0.24%
-33.9%
Q2 2023$20,222,800
-52.9%
8,322,140
+11.7%
0.37%
-56.5%
Q1 2023$42,895,526
-35.6%
7,447,1400.0%0.84%
-33.9%
Q4 2022$66,577,432
-37.1%
7,447,1400.0%1.27%
-35.2%
Q3 2022$105,898,000
-2.6%
7,447,140
-0.0%
1.97%
-0.2%
Q2 2022$108,728,000
-26.9%
7,447,1410.0%1.97%
-18.3%
Q1 2022$148,719,000
+14.2%
7,447,1410.0%2.41%
+44.0%
Q4 2021$130,250,000
+129.7%
7,447,141
+3.0%
1.67%
+168.7%
Q3 2021$56,706,000
-23.8%
7,232,8560.0%0.62%
-17.3%
Q2 2021$74,426,000
-21.3%
7,232,8560.0%0.75%
-14.9%
Q1 2021$94,606,000
+0.4%
7,232,856
+7.8%
0.88%
+7.3%
Q4 2020$94,255,000
+18.2%
6,708,5070.0%0.82%
-17.7%
Q3 2020$79,764,0006,708,5071.00%
Other shareholders
ADICET BIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 558,636$3,217,7432.38%
TANG CAPITAL MANAGEMENT LLC 2,520,000$14,515,2002.16%
COWEN AND COMPANY, LLC 3,143,608$18,107,1822.13%
DAFNA Capital Management LLC 797,054$4,591,0311.38%
JOHNSON & JOHNSON 728,944$4,198,7171.37%
Decheng Capital Management III (Cayman), LLC 580,000$3,340,8001.35%
Orbimed Advisors 7,447,140$42,895,5260.84%
EcoR1 Capital, LLC 3,560,700$20,509,6320.66%
Granite Point Capital Management, L.P. 65,729$378,5990.52%
RTW INVESTMENTS, LP 4,241,472$24,430,8790.51%
View complete list of ADICET BIO INC shareholders